Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Pral1688g00020 | ATGACAGAGGTAACTTTACAAATACAACATCCTGATAGAGTAAGCACAATTGGGCTATGTCGAGGAGATATCACACCAGATGAATGCCATGCTTGCCTCAAGAATGCCTCACTTATTCTCCCTATGTCGTGTCCAAATATGAGGGAGGCTATGGCAGGCTCCGACGAGTGCTTTCTCCGACAATCAAACTGCTCAATATTTAGGGTCATGGAATCTAACGCTTCGTGCATATGGTGGAACAGGTATGATACAGCAGAGCAGGACAAGTACAATGAAGTTAGTGGATTATTGGAAGGACTGAGAAGCAAAGCGAAGAATGGAGATTCACTTCTTAAGTATGCAGAAGCATATCAAACGGCTTCAAACTTGCAAAACATATTTGGTGGGGTTCAGTGCACTCCTGATTTGTCTCAGCAAGATTGCTCTGACTGCTTGAAGACCGCTATCTCTGAACTTCCCAATTGTTGTTTCGCAAAGAGAGGTGGTAGGGTTATCAAACCCAGCTGCAATGTTAGGTATGAGAACTACCGTTTCTTTGGTCCCATGGCTGAGGATTCACCACCGCTGCCGCCGTCTCCTCTTTCCCCTCCAACGACGTCCACCTCAAAAGGGCATAGTAGACAGTCAATCATTACTAGCATTGCCATTGGTAAGCTCCATAATGGAGAAGTTGCTGTCAAAAGGTTATCCAACAATTCTGGGCAAGGAGATATAGAATTTAAGAGTGAAGTAAAGTTGGTGGCTAAGCTTCAGCATCGCAATTTGGCTAGACTCCTTGGTTTCTGTTTGGAAAGAGGAGAAAGACTTCTCATCTATGAGTTTCTTCCCAATAAAAGTCTTGACTACCTGTTATTTGGCAAGTTACAACTTCCTGAGTTGAGATCTATCTACTGTTTCCATAGCAGAGGTAACTTTACAAATTCGAGTACGTACCAAACCAACCTTAACATCGTCCTTTCAGATCTCACTTCCAACACAGCAATTGACTATGGCTTCTACAATTTGTCTCATGGCCAGTATCCTTATAGAGTCAGCGCAATTGGGTTATGTCGAGGAGATATTAAACCAAATGAATGCCGTTCTTGTCTCAAGAATGCCTCAGTTCTTGTCCCTATGTTGTGTCCGAATATGAAGGAGGCTATGGGAGGCTACGACGAATGCTTTCTCCGATACTCAAACCGCTCAATATTTGGGGTCATGGAATCTGACGCTTCATTCATATTGTGGAACAAGTATGATACAACAGATCAGGACAAGTACAACGAAGTGGTTAGTGAGTTGTTGGAAGGACTGAGAAGCAAAGCTAAGAATGGAGATTCACTTCGTAAATATGCAGAAGCAAATCAAGCGGGTCCAAACTTTTACACCATATACGGTGCAGTTCAGTGCACTCCTGATTTGTCTCAGCAAGATTGCTCCGACTGCTTGAAGACGGCTATCTCTGAACTTCCCGGTTGTTGTTTCACAAAGAGAGGTGGCAGGGTTATCAAACCCAGCTGCAACGTCAGGTACGAGAACTACCGTTTCTTTGGTCCTGTGGCTGAGCATTCACCACTGCCGCCGCCGTCTCCTATTTCCCCTCCGAGGACACCCACCTCAAAAGGGCATAGCCGAAAATCAATCAAGACTATCATTGCCATAGTTTTGCCAACTGTTGCAACCATCTTACTGCTCATCTCTGTCTTCAGTATTATTTGTTTGAGAATGAGGAAAACCAGGGACGCAATTCAGAAGGAAGCAGAACTTGATGATGAAACTGAATTTATTGAGTCATTACAGTTAGATTTTGAAACCATCAGAACTGCAACAGATAATTTCTCTGATGCAAATAAACTTGGACAAGGTGGATTTGGACCAGTTTATAAGGGTAAGCTCCATAATGGAGAAGAAGTTGCTGTCAAAAGGTTATCCAAGAATTCTGGGCAAGGAGACATAGAATTTAAGAATGAAGTAAAGTTGATGGCTAAGCTTCAGCATCGCAATTTAGCTAGACTCCGTGGCTTCTGTTTGGAAAGAGAAGAAAGACTTCTCATCTATGAGTTTCTTCCCAATAAAAGTCTTGACTACTTATTATTTGATCCAAATCATCGTGCTCAACTGAATTGGGAGATGCGTCACAAAATTATCATGGGCGTAGCTCGTGGCCTTCATTATCTCCATCAAGATTCCCAGCTACGAATTATTCATCGTGATCTCAAAGCAAGTAATATTCTTTTAGATGCAGAGTTGAATCCCAAGATATCTGATTTTGGCATGGCAAGATTATTTGCTATGGATCAATCTCAAAGTAACACTAGTAGAATTGTTGGAACTTATGGATATATGGCTCCAGAGTATGCAATGCGTGGGCAATTCTCAATCAAATCAGATGTCTTTAGTTTCGGTGTGCTAATCCTAGAGATTATATGTGGGAAGAAAAACAACAGCATCTTTCATGAAGAGAATATACTGAATCTACTGAGCTTTGTATGGAAAAACTGGAGAGAAGGGACAACCTCAAATATAGTAGATCCTGTATTAAACAATGCGTCAAGCAATGAAATAAAGAGATGCATCCATATTGGGTTGCTATGCGTTCAGGAAAATGTAGCTGATAGGCCAACCATGGCTTCAGTTGCTCTAATGCTTGATAGCCACTCTATAACTCTCTCAGTACCATCCGAACCTCCATTTTTAATGTATAACAGAAGCTTACCAGAAACGAATTCTGGGGAGAATAATTCATCAGGGGCCACAAGATCAGCTGAAGGAGGAAGAGACTATGTTGAAGCCTCAACAAATGAAGTCACAATAACTGAGCTTCATCCTCGCTAA | 2814 | 0.4204 | MTEVTLQIQHPDRVSTIGLCRGDITPDECHACLKNASLILPMSCPNMREAMAGSDECFLRQSNCSIFRVMESNASCIWWNRYDTAEQDKYNEVSGLLEGLRSKAKNGDSLLKYAEAYQTASNLQNIFGGVQCTPDLSQQDCSDCLKTAISELPNCCFAKRGGRVIKPSCNVRYENYRFFGPMAEDSPPLPPSPLSPPTTSTSKGHSRQSIITSIAIGKLHNGEVAVKRLSNNSGQGDIEFKSEVKLVAKLQHRNLARLLGFCLERGERLLIYEFLPNKSLDYLLFGKLQLPELRSIYCFHSRGNFTNSSTYQTNLNIVLSDLTSNTAIDYGFYNLSHGQYPYRVSAIGLCRGDIKPNECRSCLKNASVLVPMLCPNMKEAMGGYDECFLRYSNRSIFGVMESDASFILWNKYDTTDQDKYNEVVSELLEGLRSKAKNGDSLRKYAEANQAGPNFYTIYGAVQCTPDLSQQDCSDCLKTAISELPGCCFTKRGGRVIKPSCNVRYENYRFFGPVAEHSPLPPPSPISPPRTPTSKGHSRKSIKTIIAIVLPTVATILLLISVFSIICLRMRKTRDAIQKEAELDDETEFIESLQLDFETIRTATDNFSDANKLGQGGFGPVYKGKLHNGEEVAVKRLSKNSGQGDIEFKNEVKLMAKLQHRNLARLRGFCLEREERLLIYEFLPNKSLDYLLFDPNHRAQLNWEMRHKIIMGVARGLHYLHQDSQLRIIHRDLKASNILLDAELNPKISDFGMARLFAMDQSQSNTSRIVGTYGYMAPEYAMRGQFSIKSDVFSFGVLILEIICGKKNNSIFHEENILNLLSFVWKNWREGTTSNIVDPVLNNASSNEIKRCIHIGLLCVQENVADRPTMASVALMLDSHSITLSVPSEPPFLMYNRSLPETNSGENNSSGATRSAEGGRDYVEASTNEVTITELHPR | 937 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Pral1688g00020 | 937 | MobiDBLite | consensus disorder prediction | 896 | 937 | - | - | |
Pral1688g00020 | 937 | FunFam | cysteine-rich receptor-like protein kinase 10 | 682 | 883 | - | - | |
Pral1688g00020 | 937 | Gene3D | Phosphorylase Kinase; domain 1 | 199 | 274 | - | - | |
Pral1688g00020 | 937 | ProSiteProfiles | Gnk2-homologous domain profile. | 71 | 178 | IPR002902 | - | |
Pral1688g00020 | 937 | MobiDBLite | consensus disorder prediction | 184 | 206 | - | - | |
Pral1688g00020 | 937 | Gene3D | Phosphorylase Kinase; domain 1 | 568 | 681 | - | - | |
Pral1688g00020 | 937 | ProSiteProfiles | Gnk2-homologous domain profile. | 293 | 396 | IPR002902 | - | |
Pral1688g00020 | 937 | FunFam | Cysteine-rich RLK (RECEPTOR-like protein kinase) 10 | 291 | 396 | - | - | |
Pral1688g00020 | 937 | ProSiteProfiles | Protein kinase domain profile. | 606 | 882 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Pral1688g00020 | 937 | Gene3D | Transferase(Phosphotransferase) domain 1 | 682 | 884 | - | - | |
Pral1688g00020 | 937 | PANTHER | PROMASTIGOTE SURFACE ANTIGEN PROTEIN PSA | 294 | 936 | - | - | |
Pral1688g00020 | 937 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 727 | 739 | IPR008271 | GO:0004672|GO:0006468 | |
Pral1688g00020 | 937 | FunFam | Cysteine-rich receptor-like protein kinase 10 | 568 | 681 | - | - | |
Pral1688g00020 | 937 | Gene3D | - | 293 | 395 | IPR038408 | - | |
Pral1688g00020 | 937 | Gene3D | - | 402 | 509 | IPR038408 | - | |
Pral1688g00020 | 937 | Gene3D | - | 2 | 65 | IPR038408 | - | |
Pral1688g00020 | 937 | Gene3D | - | 73 | 178 | IPR038408 | - | |
Pral1688g00020 | 937 | FunFam | Cysteine-rich receptor-like protein kinase 10 | 74 | 178 | - | - | |
Pral1688g00020 | 937 | ProSiteProfiles | Gnk2-homologous domain profile. | 1 | 66 | IPR002902 | - | |
Pral1688g00020 | 937 | SUPERFAMILY | Protein kinase-like (PK-like) | 591 | 901 | IPR011009 | - | |
Pral1688g00020 | 937 | ProSiteProfiles | Gnk2-homologous domain profile. | 402 | 509 | IPR002902 | - | |
Pral1688g00020 | 937 | MobiDBLite | consensus disorder prediction | 896 | 914 | - | - | |
Pral1688g00020 | 937 | Pfam | Salt stress response/antifungal | 90 | 176 | IPR002902 | - | |
Pral1688g00020 | 937 | Pfam | Salt stress response/antifungal | 412 | 507 | IPR002902 | - | |
Pral1688g00020 | 937 | Pfam | Salt stress response/antifungal | 298 | 393 | IPR002902 | - | |
Pral1688g00020 | 937 | Pfam | Salt stress response/antifungal | 9 | 63 | IPR002902 | - | |
Pral1688g00020 | 937 | FunFam | Cysteine-rich receptor-like protein kinase 10 | 404 | 509 | - | - | |
Pral1688g00020 | 937 | MobiDBLite | consensus disorder prediction | 518 | 537 | - | - | |
Pral1688g00020 | 937 | SMART | serkin_6 | 606 | 882 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Pral1688g00020 | 937 | SUPERFAMILY | Protein kinase-like (PK-like) | 219 | 296 | IPR011009 | - | |
Pral1688g00020 | 937 | Pfam | Protein tyrosine and serine/threonine kinase | 610 | 872 | IPR001245 | GO:0004672|GO:0006468 | |
Pral1688g00020 | 937 | Pfam | Protein tyrosine and serine/threonine kinase | 219 | 287 | IPR001245 | GO:0004672|GO:0006468 | |
Pral1688g00020 | 937 | CDD | STKc_IRAK | 612 | 877 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Pral1688g00020 | Pral-Chr1688 | 267922 | 280788 | Dispersed/Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Pral1688g00020 | 302 | 937 | Receptor kinase-like Gene Family | AT4G21410 | 49.238 | 0.0 | 597 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | RLK-Pelle_DLSV | Pral1688g00020 | PK_Tyr_Ser-Thr | 7.5e-48 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Pral1688g00020 | - | - | lang:109353867 | 794.653 |